Cargando…

High-dose olanzapine in treatment resistant schizophrenia. A case report and literature review

OBJECTIVE: We report a case of a 58-year-old gentleman who was hospitalised intermittently for one year due to treatment resistant schizophrenia. Prior to hospitalisation he had been prescribed standard antipsychotics for decades without full resolution of positive psychotic symptoms. During his fin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clarke, Ciara, Rushe, Clodagh, Byrne, Fintan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Case Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770351/ http://dx.doi.org/10.1192/bjo.2021.335

Ejemplares similares

High-dose olanzapine in treatment-resistant schizophrenia: a systematic review
por: Gannon, Louisa, et al.
Publicado: (2023)

Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine
por: Fitzgerald, Ita, et al.
Publicado: (2021)

Repetitive transcranial magnetic stimulation combined with olanzapine and amisulpride for treatment-refractory schizophrenia
por: Liu, Jin-Ling, et al.
Publicado: (2023)

A Comparative Study between Olanzapine and Risperidone in the Management of Schizophrenia
por: Shoja Shafti, Saeed, et al.
Publicado: (2014)

Paroxetine combined with olanzapine in the treatment of schizophrenia
por: Wang, Ning, et al.
Publicado: (2020)

Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review
por: Xue, Hai Bo Haber, et al.
Publicado: (2014)

Effects of low-dose combined olanzapine and sertraline on negative and depressive symptoms in treatment-resistant outpatients with acute exacerbated schizophrenia
por: Lang, Xiaoe, et al.
Publicado: (2023)

Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia
por: Katagiri, Hideaki, et al.
Publicado: (2018)

Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics
por: Liu-Seifert, Hong, et al.
Publicado: (2011)

Thrombocytopenia associated with olanzapine: A case report and review of literature
por: Sahoo, Swapnajeet, et al.
Publicado: (2016)

Treatment of Central Vertigo With Low Dose Olanzapine: Report of Two Cases
por: Jiang, Connie, et al.
Publicado: (2022)

Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report
por: Ifteni, Petru, et al.
Publicado: (2014)

Efficacy of Olanzapine Combined Therapy for Patients Receiving Highly Emetogenic Chemotherapy Resistant to Standard Antiemetic Therapy
por: Abe, Masakazu, et al.
Publicado: (2015)

Application of Plasma Levels of Olanzapine and N-Desmethyl-Olanzapine to Monitor Clinical Efficacy in Patients with Schizophrenia
por: Lu, Mong-Liang, et al.
Publicado: (2016)

Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia
por: An, Huimei, et al.
Publicado: (2022)

Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia Patients
por: Zhou, Wei, et al.
Publicado: (2019)

A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future
por: Citrome, Leslie, et al.
Publicado: (2019)

Effect of Co-Treatment of Olanzapine with SEP-363856 in Mice Models of Schizophrenia
por: Liang, Lingzhi, et al.
Publicado: (2022)

Whole-body edema with olanzapine: A case report and literature review
por: Cook, Elizabeth A., et al.
Publicado: (2020)

Effects of olanzapine treatment on lipid profiles in patients with schizophrenia: a systematic review and meta-analysis
por: Li, Rong, et al.
Publicado: (2020)

Macrophage-derived secretome is sufficient to confer olanzapine-mediated insulin resistance in human adipocytes
por: Dipta, Priya, et al.
Publicado: (2021)

Effect of Olanzapine on Clinical and Polysomnography Profiles in Patients with Schizophrenia
por: Katshu, Mohammad Zia Ul Haq, et al.
Publicado: (2018)

Dose-Dependent Olanzapine-Induced Myoclonus
por: Tikka, Sai Krishna, et al.
Publicado: (2014)

The Effect of Ranitidine on Olanzapine-Induced Weight Gain
por: Ranjbar, Fatemeh, et al.
Publicado: (2013)

Reasons for continuing or discontinuing olanzapine in the treatment of schizophrenia from the perspectives of patients and clinicians
por: Chen, Jian, et al.
Publicado: (2011)

Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia
por: Di Lorenzo, Rosaria, et al.
Publicado: (2010)

Olanzapine has better efficacy compared to risperidone for treatment of negative symptoms in schizophrenia
por: Suresh Kumar, P. N., et al.
Publicado: (2016)

Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia
por: Vadlamani, Laxmi Naresh, et al.
Publicado: (2017)

Effect of olanzapine combined with risperidone in the treatment of schizophrenia and its influence on cognitive function
por: Yang, Lujie, et al.
Publicado: (2021)

Olanzapine-induced restless leg syndrome: A case report and review of literature
por: Basu, Aniruddha, et al.
Publicado: (2014)

Effects of olanzapine on resting heart rate in Japanese patients with schizophrenia
por: Tajiri, Misuzu, et al.
Publicado: (2018)

Subcutaneous Olanzapine at the End of Life in a Patient with Schizophrenia and Dysphagia
por: Hindmarsh, Jonathan, et al.
Publicado: (2020)

Prevalence of diabetes in patients of Schizophrenia on long-term use of olanzapine
Publicado: (2022)

Effects of olanzapine on anhedonia in schizophrenia: mediated by complement factor H
por: Zhang, Yi, et al.
Publicado: (2023)

Schizophrenia-like psychosis and gitelman syndrome: a case report and literature review
por: Pan, Bing, et al.
Publicado: (2016)

Olanzapine as an Adjunct in the Management of Refractory Psychogenic Excoriation With Comorbid Schizophrenia: A Case Report
por: Yeager, Violet, et al.
Publicado: (2020)

Breast enlargement associated with low dose olanzapine
por: Aggarwal, Ashish, et al.
Publicado: (2011)

A Flexible-Dose Study of Paliperidone ER in Patients With Nonacute Schizophrenia Previously Treated Unsuccessfully With Oral Olanzapine
por: KOTLER, MOSHE, et al.
Publicado: (2016)

A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2004)

OLANZAPINE IN THE TREATMENT OF SCHIZOPHRENIA : AN OPEN LABEL COMPARATIVE CLINICAL TRIAL FROM NORTH INDIA
por: Avasthi, Ajit, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_lnhs7v1m0clquvmrgnjvp67828